Spinosad
多杀霉素
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameSpinosad
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2011/01/18
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Active CompaniesCipher Pharmaceuticals Inc
Inactive CompaniesParapro Llc
Active Indications
Inactive IndicationsN/A